281 related articles for article (PubMed ID: 28615705)
1. A Long-Term and Slow-Releasing Hydrogen Sulfide Donor Protects against Myocardial Ischemia/Reperfusion Injury.
Sun X; Wang W; Dai J; Jin S; Huang J; Guo C; Wang C; Pang L; Wang Y
Sci Rep; 2017 Jun; 7(1):3541. PubMed ID: 28615705
[TBL] [Abstract][Full Text] [Related]
2. Donor heart preservation with a novel long-term and slow-releasing hydrogen sulfide system.
Sun X; Wang W; Dai J; Huang J; Shi M; Chu X; Wang F; Guo C; Wang C; Pang L; Wang Y
Nitric Oxide; 2018 Dec; 81():1-10. PubMed ID: 30217578
[TBL] [Abstract][Full Text] [Related]
3. An in situ slow-releasing H
Hsieh MH; Tsai HW; Lin KJ; Wu ZY; Hu HY; Chang Y; Wei HJ; Sung HW
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109954. PubMed ID: 31500027
[TBL] [Abstract][Full Text] [Related]
4. PI3K/SGK1/GSK3β signaling pathway is involved in inhibition of autophagy in neonatal rat cardiomyocytes exposed to hypoxia/reoxygenation by hydrogen sulfide.
Jiang H; Xiao J; Kang B; Zhu X; Xin N; Wang Z
Exp Cell Res; 2016 Jul; 345(2):134-40. PubMed ID: 26163895
[TBL] [Abstract][Full Text] [Related]
5. The novel H
Testai L; Marino A; Piano I; Brancaleone V; Tomita K; Di Cesare Mannelli L; Martelli A; Citi V; Breschi MC; Levi R; Gargini C; Bucci M; Cirino G; Ghelardini C; Calderone V
Pharmacol Res; 2016 Nov; 113(Pt A):290-299. PubMed ID: 27616550
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen sulfide protects cardiomyocytes from myocardial ischemia-reperfusion injury by enhancing phosphorylation of apoptosis repressor with caspase recruitment domain.
Yao X; Tan G; He C; Gao Y; Pan S; Jiang H; Zhang Y; Sun X
Tohoku J Exp Med; 2012 Apr; 226(4):275-85. PubMed ID: 22499119
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen sulfide contributes to cardioprotection during ischemia-reperfusion injury by opening K ATP channels.
Zhang Z; Huang H; Liu P; Tang C; Wang J
Can J Physiol Pharmacol; 2007 Dec; 85(12):1248-53. PubMed ID: 18066126
[TBL] [Abstract][Full Text] [Related]
8. Controlled release hydrogen sulfide delivery system based on mesoporous silica nanoparticles protects graft endothelium from ischemia-reperfusion injury.
Wang W; Sun X; Zhang H; Yang C; Liu Y; Yang W; Guo C; Wang C
Int J Nanomedicine; 2016; 11():3255-63. PubMed ID: 27486324
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-21-Regulated Activation of the Akt Pathway Participates in the Protective Effects of H
Lu M; Jiang X; Tong L; Zhang F; Ma L; Dong X; Sun X
Biol Pharm Bull; 2018 Feb; 41(2):229-238. PubMed ID: 29187695
[TBL] [Abstract][Full Text] [Related]
10. Hydrogen sulfide preconditioning protects against myocardial ischemia/reperfusion injury in rats through inhibition of endo/sarcoplasmic reticulum stress.
Li C; Hu M; Wang Y; Lu H; Deng J; Yan X
Int J Clin Exp Pathol; 2015; 8(7):7740-51. PubMed ID: 26339339
[TBL] [Abstract][Full Text] [Related]
11. Diallyl trisulfide protects against high glucose-induced cardiac apoptosis by stimulating the production of cystathionine gamma-lyase-derived hydrogen sulfide.
Tsai CY; Wen SY; Shibu MA; Yang YC; Peng H; Wang B; Wei YM; Chang HY; Lee CY; Huang CY; Kuo WW
Int J Cardiol; 2015 Sep; 195():300-10. PubMed ID: 26056963
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen sulfide protects against myocardial ischemia and reperfusion injury by activating AMP-activated protein kinase to restore autophagic flux.
Xie H; Xu Q; Jia J; Ao G; Sun Y; Hu L; Alkayed NJ; Wang C; Cheng J
Biochem Biophys Res Commun; 2015 Mar; 458(3):632-638. PubMed ID: 25684185
[TBL] [Abstract][Full Text] [Related]
13. The route and timing of hydrogen sulfide therapy critically impacts intestinal recovery following ischemia and reperfusion injury.
Jensen AR; Drucker NA; Te Winkel JP; Ferkowicz MJ; Markel TA
J Pediatr Surg; 2018 Jun; 53(6):1111-1117. PubMed ID: 29622397
[TBL] [Abstract][Full Text] [Related]
14. Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia-reperfusion injury--Evidence for a role of K ATP channels.
Johansen D; Ytrehus K; Baxter GF
Basic Res Cardiol; 2006 Jan; 101(1):53-60. PubMed ID: 16328106
[TBL] [Abstract][Full Text] [Related]
15. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat.
Sivarajah A; McDonald MC; Thiemermann C
Shock; 2006 Aug; 26(2):154-61. PubMed ID: 16878023
[TBL] [Abstract][Full Text] [Related]
16. Novel controlled and targeted releasing hydrogen sulfide system exerts combinational cerebral and myocardial protection after cardiac arrest.
Sun X; Wang Y; Wen S; Huang K; Huang J; Chu X; Wang F; Pang L
J Nanobiotechnology; 2021 Feb; 19(1):40. PubMed ID: 33549092
[TBL] [Abstract][Full Text] [Related]
17. Delivery of Hydrogen Sulfide by Ultrasound Targeted Microbubble Destruction Attenuates Myocardial Ischemia-reperfusion Injury.
Chen G; Yang L; Zhong L; Kutty S; Wang Y; Cui K; Xiu J; Cao S; Huang Q; Liao W; Liao Y; Wu J; Zhang W; Bin J
Sci Rep; 2016 Jul; 6():30643. PubMed ID: 27469291
[TBL] [Abstract][Full Text] [Related]
18. Involvement of MicroRNA-133a in the Protective Effect of Hydrogen Sulfide against Ischemia/Reperfusion-Induced Endoplasmic Reticulum Stress and Cardiomyocyte Apoptosis.
Ren L; Wang Q; Chen Y; Ma Y; Wang D
Pharmacology; 2019; 103(1-2):1-9. PubMed ID: 30326468
[TBL] [Abstract][Full Text] [Related]
19. Involvement of exogenous H2S in recovery of cardioprotection from ischemic post-conditioning via increase of autophagy in the aged hearts.
Chen J; Gao J; Sun W; Li L; Wang Y; Bai S; Li X; Wang R; Wu L; Li H; Xu C
Int J Cardiol; 2016 Oct; 220():681-92. PubMed ID: 27393850
[TBL] [Abstract][Full Text] [Related]
20. Compared effects of inhibition and exogenous administration of hydrogen sulphide in ischaemia-reperfusion injury.
Issa K; Kimmoun A; Collin S; Ganster F; Fremont-Orlowski S; Asfar P; Mertes PM; Levy B
Crit Care; 2013 Jul; 17(4):R129. PubMed ID: 23841996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
